For Research Purposes Only

weight-loss Stack

Dual-Action Weight Loss Stack

Tirzepatide + AOD-9604

Pairs the powerful dual GIP/GLP-1 agonist tirzepatide with AOD-9604, a GH fragment specifically designed for fat metabolism without typical GH side effects.

Purpose

Enhanced weight loss with targeted fat burning

How They Work Together

Tirzepatide provides superior appetite control and metabolic benefits via dual receptor activation, while AOD-9604 enhances lipolysis in fat cells. The combination may accelerate fat loss beyond tirzepatide alone.

Protocol

tirzepatide
2.5mg weekly, titrate to 10-15mg weekly
aod9604
250-500mcg daily, morning fasted
duration
12-16 weeks minimum
notes
AOD-9604 has minimal interaction risk. Best results with fasted cardio.

Best For

Maximum weight lossResistant fat areasThose tolerating GLP-1s wellBody recomposition

Important Warnings

  • !Tirzepatide requires prescription
  • !AOD-9604 banned from compounding by FDA
  • !GI side effects from tirzepatide
  • !Supply constraints

Alternatives

Semaglutide + TesamorelinTirzepatide alone at max dose

Frequently Asked Questions

What is the Dual-Action Weight Loss Stack?

The Dual-Action Weight Loss Stack combines Tirzepatide + AOD-9604 for Enhanced weight loss with targeted fat burning. Pairs the powerful dual GIP/GLP-1 agonist tirzepatide with AOD-9604, a GH fragment specifically designed for fat metabolism without typical GH side effects.

How do Tirzepatide and AOD-9604 work together?

Tirzepatide provides superior appetite control and metabolic benefits via dual receptor activation, while AOD-9604 enhances lipolysis in fat cells. The combination may accelerate fat loss beyond tirzepatide alone.

What is the recommended Dual-Action Weight Loss Stack protocol?

tirzepatide: 2.5mg weekly, titrate to 10-15mg weekly. aod9604: 250-500mcg daily, morning fasted. duration: 12-16 weeks minimum. notes: AOD-9604 has minimal interaction risk. Best results with fasted cardio.

Is the Dual-Action Weight Loss Stack safe?

The Dual-Action Weight Loss Stack has not been studied in human clinical trials as a combination. Potential concerns include: Tirzepatide requires prescription, AOD-9604 banned from compounding by FDA, GI side effects from tirzepatide. Always consult a healthcare provider before use.

What are alternatives to the Dual-Action Weight Loss Stack?

Alternatives include: Semaglutide + Tesamorelin, Tirzepatide alone at max dose. The best option depends on your specific goals and health status.

Related Stacks

Learn More

Disclaimer: This peptide stack information is for educational purposes only. Combining peptides has not been studied in clinical trials. Always consult qualified healthcare professionals before considering any peptide protocol.